Home / Technology / Science Corp Pioneers Post-Screen Tech Era
Science Corp Pioneers Post-Screen Tech Era
16 Sep
Summary
- Science Corp is leading U.S. human trials for biohybrid brain-computer interfaces.
- The PRIMA implant has successfully restored eyesight in individuals with vision loss.
- The company has raised $230 million and aims to heal brain cells and treat neurological conditions.
Science Corporation, led by CEO Max Hodak, is pioneering a new era of human-computer interaction with its advanced brain-computer interface (BCI) technology. The company is currently spearheading the first U.S. human trials for its biohybrid BCI, aiming to redefine how humans engage with machines.
Hodak, a visionary in neural engineering, previously co-founded Neuralink. His current venture, Science Corp, focuses on applications that assist individuals with vision, cognition, and mobility impairments. The PRIMA implant has already demonstrated success by restoring sight to those with severe vision loss.
Having secured $230 million in Series C funding, Science Corp's ambitions extend to healing damaged brain cells and potentially treating conditions like Parkinson's disease and preventing seizures. Hodak is set to present these advancements at TechCrunch Disrupt 2026, exploring a post-screen future.
